These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 9845755
1. Follow-up of atypical glandular cells in cervical-endocervical smears. Schindler S, Pooley RJ, De Frias DV, Yu GH, Bedrossian CW. Ann Diagn Pathol; 1998 Oct; 2(5):312-7. PubMed ID: 9845755 [Abstract] [Full Text] [Related]
2. AGUS in cervical endometriosis. Symonds DA, Reed TP, Didolkar SM, Graham RR. J Reprod Med; 1997 Jan; 42(1):39-43. PubMed ID: 9018644 [Abstract] [Full Text] [Related]
3. Histologic follow-up of atypical endocervical cells. Liquid-based, thin-layer preparation vs. conventional Pap smear. Wang N, Emancipator SN, Rose P, Rodriguez M, Abdul-Karim FW. Acta Cytol; 2002 Jan; 46(3):453-7. PubMed ID: 12040636 [Abstract] [Full Text] [Related]
4. Cytology-histology correlation of atypical glandular cells on cervical Papanicolaou tests: A study of 628 cases. Hassan D, Findley J, Braun A, Cheng L, Yan L. J Am Soc Cytopathol; 2024 Jan; 13(5):377-385. PubMed ID: 38942649 [Abstract] [Full Text] [Related]
5. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, Shim JU. Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049 [Abstract] [Full Text] [Related]
9. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Liao SY, Stanbridge EJ. Cancer; 2000 Mar 01; 88(5):1108-21. PubMed ID: 10699902 [Abstract] [Full Text] [Related]
10. Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan. Toyoda S, Kawaguchi R, Kobayashi H. Acta Cytol; 2019 Mar 01; 63(5):361-370. PubMed ID: 31048578 [Abstract] [Full Text] [Related]
11. Atypical glandular cells: new Bethesda Terminology and Management Guidelines. Levine L, Lucci JA, Dinh TV. Obstet Gynecol Surv; 2003 Jun 01; 58(6):399-406. PubMed ID: 12775944 [Abstract] [Full Text] [Related]
12. Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Selvaggi SM, Haefner HK. Diagn Cytopathol; 1997 Feb 01; 16(2):168-73. PubMed ID: 9067112 [Abstract] [Full Text] [Related]
14. Reclassification and analysis of clinical significance of atypical glandular cells on ThinPrep using Bethesda 2001: Geneva experience. Kumar N, Bongiovanni M, Molliet MJ, Pelte MF, Egger JF, Pache JC. Swiss Med Wkly; 2007 Nov 17; 137(45-46):635-41. PubMed ID: 18027109 [Abstract] [Full Text] [Related]
15. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Soofer SB, Sidawy MK. Cancer; 2000 Aug 25; 90(4):207-14. PubMed ID: 10966560 [Abstract] [Full Text] [Related]
16. Increased diagnostic accuracy of atypical glandular cells in cervical liquid-based cytology using cell blocks. Risse EK, Holierhoek JP, Meijer-Marres EM, Ouwerkerk-Noordam E, Boon ME. Cytopathology; 2011 Aug 25; 22(4):253-60. PubMed ID: 20726867 [Abstract] [Full Text] [Related]